dihexa cancer AngIV-Analog Dihexa Rescues Cognitive Impairment
Description
Leblanc, A
The peptide stimulates healthy fibroblast growth while inhibiting cancer cell growth at 1-10 nanomolar, demonstrating selective proliferation control based on cellular health status
This is consistent with the phase 2b clinical trial, where the total 12-week result was 2.8kg (6.2 lbs) additional fat loss versus placebo (clinical trial data)
BPC 157 promotes tissue repair by interacting with growth hormone receptors, facilitating blood vessel formation, and enhancing the production of growth factors
